Chengyun Pan Selected Research

Daunorubicin (Cerubidine)

1/2021	TANK-binding kinase 1 inhibitor GSK8612 enhances daunorubicin sensitivity in acute myeloid leukemia cells via the AKT-CDK2 pathway.
10/2020	Bone marrow mesenchymal stem cells in microenvironment transform into cancer-associated fibroblasts to promote the progression of B-cell acute lymphoblastic leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chengyun Pan Research Topics

Disease

10	Neoplasms (Cancer) 01/2023 - 08/2017
6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 01/2021
5	Leukemia 01/2023 - 10/2020
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2020 - 08/2017
1	Disease Progression 01/2023
1	Carcinogenesis 01/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022
1	Turcot syndrome 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 09/2020
1	Blast Crisis (Blast Phase) 09/2020
1	Hypoxia (Hypoxemia) 02/2018
1	Philadelphia Chromosome 08/2017

Drug/Important Bio-Agent (IBA)

4	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2023 - 02/2022
3	Tyrosine Kinase InhibitorsIBA 09/2020 - 08/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2021
2	Heme Oxygenase-1IBA 01/2023 - 02/2022
2	NF-E2-Related Factor 2IBA 01/2023 - 11/2022
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2021
2	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2021 - 10/2020
2	Imatinib Mesylate (Gleevec)FDA Link 09/2020 - 08/2017
1	TH5487IBA 01/2023
1	8-hydroxyguanineIBA 01/2023
1	A-factor (Streptomyces)IBA 01/2023
1	Glycoside Hydrolases (Endoglycosidases)IBA 01/2023
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2023
1	InterferonsIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	HLA-C Antigens (HLA-C)IBA 01/2023
1	Interferon-alpha (Interferon Alfa)IBA 01/2023
1	mitogen and stress-activated protein kinase 1IBA 02/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Vincristine (Oncovin)FDA LinkGeneric 01/2022
1	IntegrinsIBA 01/2021
1	MutS ProteinsIBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	plerixafor FDA Link 01/2021
1	Fibronectins (Fibronectin)IBA 01/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2020
1	CateninsIBA 09/2020
1	Histone Deacetylase InhibitorsIBA 09/2020
1	N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamideIBA 09/2020
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 02/2018
1	UbiquitinIBA 02/2018
1	Ligases (Synthetase)IBA 02/2018
1	Vitamin K 3 (Menadione)FDA Link 02/2018
1	Tigecycline (Tygacil)FDA Link 10/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2017
1	nilotinib FDA Link 08/2017
1	Dasatinib (BMS 354825)FDA Link 08/2017

Therapy/Procedure

4	Drug Therapy (Chemotherapy) 01/2023 - 10/2017
2	Therapeutics 10/2020 - 08/2017